Remyelination after cuprizone-induced demyelination in the rat is stimulated by apotransferrin

Twenty-one-day-old Wistar rats were fed a diet containing 0.6% cuprizone for 2 weeks. Studies carried out after withdrawal of cuprizone showed histological evidences of marked demyelination in the corpus callosum. Biochemical studies of isolated myelin showed a marked decrease in myelin proteins, ph...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Adamo, A.M
Otros Autores: Paez, P.M, Escobar Cabrera, O.E, Wolfson, M., Franco, P.G, Pasquini, J.M, Soto, E.F
Formato: Capítulo de libro
Lenguaje:Inglés
Publicado: 2006
Materias:
Acceso en línea:Registro en Scopus
DOI
Handle
Registro en la Biblioteca Digital
Aporte de:Registro referencial: Solicitar el recurso aquí
LEADER 13170caa a22015257a 4500
001 PAPER-21841
003 AR-BaUEN
005 20230518205320.0
008 190411s2006 xx ||||fo|||| 00| 0 eng|d
024 7 |2 scopus  |a 2-s2.0-33645729410 
024 7 |2 cas  |a broxuridine, 59-14-3; cuprizone, 370-81-0; galactosylceramide, 85305-88-0; Antigens; Antigens, CD11b; Apoproteins; apotransferrin; Bromodeoxyuridine, 59-14-3; chondroitin sulfate proteoglycan 4; Cuprizone, 370-81-0; Cytoskeletal Proteins; DAPI, 47165-04-8; Galactolipids; Glial Fibrillary Acidic Protein; Indoles; Myelin Basic Proteins; Proteoglycans; Transferrin, 11096-37-0 
040 |a Scopus  |b spa  |c AR-BaUEN  |d AR-BaUEN 
030 |a EXNEA 
100 1 |a Adamo, A.M. 
245 1 0 |a Remyelination after cuprizone-induced demyelination in the rat is stimulated by apotransferrin 
260 |c 2006 
270 1 0 |m Soto, E.F.; Instituto de Química y Físicoquímica Biológica (IQUIFIB), UBA-CONICET, Departamento de Química Biológica, Buenos Aires, C1113AAD, Argentina; email: edufsoto@mail.retina.ar 
506 |2 openaire  |e Política editorial 
504 |a Armstrong, R.C., Le, T.Q., Frost, E.E., Borke, R.C., Vana, A.C., Absence of fibroblast growth factor 2 promotes oligodendroglial repopulation of demyelinated white matter (2002) J. Neurosci., 22, pp. 8574-8585 
504 |a Arnett, H.A., Mason, J., Marino, M., Suzuki, K., Matsushima, G.K., Ting, J.P.-Y., TNFα promotes proliferation of oligodendrocyte progenitors and remyelination (2001) Nat. Neurosci., 4, pp. 1116-1122 
504 |a Blakemore, W.F., Demyelination of the superior cerebellar peduncle in the mouse induced by cuprizone (1973) J. Neurol. Sci., 20, pp. 63-72 
504 |a Blakemore, W.F., Remyelination of the superior cerebellar peduncle in old mice following demyelination induced by cuprizone (1974) J. Neurol. Sci., 22, pp. 121-127 
504 |a Cammer, W., The neurotoxicant, cuprizone, retards the differentiation of oligodendrocytes in vitro (1999) J. Neurol. Sci., 168, pp. 116-120 
504 |a Cammer, W., Zhang, H., Atypical localization of the oligodendrocytic isoform (PI) of glutathion-S-transferase in astrocytes during cuprizone intoxication (1993) J. Neurosci. Res., 36, pp. 183-190 
504 |a Carlton, W.W., Spongiform encephalopathy induced in rats and guinea pigs by cuprizone (1969) Exp. Mol. Pathol., 10, pp. 274-287 
504 |a Casella, G.T.B., Bartlett Bunge, M., Wood, P.M., Improved immunocytochemical identification of neural, endothelial, and inflammatory cell types in paraffin-embedded injured adult rat spinal cord (2004) J. Neurosci. Methods, 139, pp. 1-11 
504 |a Chen, P.S., Toribara, T., Warner, H., Microdetermination of phosphorus (1956) Anal. Chem., 28, pp. 1756-1758 
504 |a Escobar Cabrera, O.E., Bongarzone, E.R., Soto, E.F., Pasquini, J.M., Single intracerebral injection of apotransferrin in young rats induces increased myelination (1994) Dev. Neurosci., 16, pp. 248-254 
504 |a Escobar Cabrera, O.E., Zakin, M.M., Soto, E.F., Pasquini, J.M., Single intracranial injection of apotransferrin in young rats increases the expression of specific myelin protein mRNA (1997) J. Neurosci. Res., 47, pp. 603-608 
504 |a Escobar Cabrera, O.E., Bongiovanni, G., Hallak, M., Soto, E.F., Pasquini, J.M., The cytoskeletal components of the myelin fraction are affected by a single intracranial injection of apotransferrin in young rats (2000) Neurochem. Res., 25, pp. 669-676 
504 |a Espinosa de los Monteros, A., Peña, L.A., de Vellis, J., Does transferrin have a special role in the nervous system (1989) J. Neurosci. Res., 24, pp. 125-136 
504 |a Espinosa de los Monteros, A., Kumar, S., Zhao, P., Huang, C.J., Nazarian, R., Pan, T., Scully, S., de Vellis, J., Transferrin is an essential factor for myelination (1999) Neurochem. Res., 24, pp. 235-248 
504 |a Espinosa-Jeffrey, A., Kumar, S., Zhao, P.M., Awosika, O., Agbo, C., Huang, A., Chang, R., De Vellis, J., Transferrin regulates transcription of the MBP gene and its action synergizes with IGF-1 to enhance myelinogenesis in the md rat (2002) Dev. Neurosci., 24, pp. 227-241 
504 |a Folch, J., Lees, M., Sloane Stanley, G.H., A simple method for the isolation and purification of total lipides from animal tissues (1957) J. Biol. Chem., 226, pp. 497-509 
504 |a Garcia, C.I., Paez, P., Soto, E.F., Pasquini, J.M., Differential effect of apotransferrin on two populations of oligodendroglial cells (2003) Glia, 42, pp. 406-416 
504 |a Hess, H.H., Lewin, E., Microassay of Biochemical structural components in nervous tissues: II. Methods for cerebrosides, proteolipid proteins and residue proteins (1965) J. Neurochem., 12, pp. 205-211 
504 |a Komoly, S., Jeyasingham, M.D., Pratt, O.E., Lantos, P.L., Decrease in oligodendrocyte carbonic anhydrase activity preceding myelin degeneration in cuprizone induced demyelination (1987) J. Neurol. Sci., 79, pp. 141-148 
504 |a Lapetina, E., Soto, E.F., de Robertis, E., Lipids and proteolipids in isolated subcellular membranes of rat brain cortex (1968) J. Neurochem., 15, pp. 437-445 
504 |a Love, S., Cuprizone neurotoxicity in the rat: morphologic observations (1988) J. Neurol. Sci., 84, pp. 223-237 
504 |a Lowry, D.H., Rosebrough, N.J., Farr, A.L., Randall, R.J., Protein measurement with the Folin phenol reagent (1951) J. Biol. Chem., 193, pp. 265-275 
504 |a Ludwin, S.K., Central nervous system demyelination and remyelination in the mouse: an ultrastructural study of cuprizone toxicity (1978) Lab. Invest., 39, pp. 597-612 
504 |a Ludwin, S., Central nervous system remyelination studies in chronically damaged tissue (1994) Ann. Neurol., 36, pp. 143-145. , (Suppl.) 
504 |a Marta, C.B., Escobar Cabrera, O.E., Garcia, C.I., Villar, M.J., Pasquini, J.M., Soto, E.F., Oligodendroglial cell differentiation in rat brain is accelerated by the intracranial injection of apotransferrin (2000) Cell. Mol. Biol., 46, pp. 529-539 
504 |a Marta, C.B., Paez, P., Lopez, M., Pellegrino de Iraldi, A., Soto, E.F., Pasquini, J.M., Morphological changes of myelin sheaths in rats intracranially injected with apotransferrin (2003) Neurochem. Res., 28, pp. 101-110 
504 |a Mason, J.L., Toews, A., Hoststtler, J.D., Morell, P., Suzuki, K., Goldman, J.E., Matsushima, G.K., Oligodendrocytes and progenitors become progressively depleted with chronically demyelinated lesions (2004) Am. J. Pathol., 164, pp. 1673-1682 
504 |a Matsushima, G.K., Morell, P., The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system (2001) Brain Pathol., 11, pp. 107-116 
504 |a Muse, E.D., Jurevics, H., Toews, A.D., Matsushima, G.K., Morell, P., Parameters related to lipid metabolism as markers of myelination in mouse brain (2001) J. Neurochem., 76, pp. 77-86 
504 |a Norton, W.T., Poduslo, S.E., Myelination in rat brain: method of myelin isolation (1973) J. Neurochem., 21, pp. 749-757 
504 |a Oberhammer, F., Fritsch, G., Schmied, M., Pavelka, M., Printz, D., Purchio, T., Lassmann, H., Schulte-Hermann, R., Condensation of the chromatin at the membrane of an apoptotic nucleus is not associated with activation of an endonuclease (1993) J. Cell. Sci., 104, pp. 66-73 
504 |a Paez, P.M., Marta, C.B., Moreno, M.B., Soto, E.F., Pasquini, J.M., Apotransferrin decreases migration and enhances differentiation of oligodendroglial progenitor cells in an in vitro system (2002) Dev. Neurosci., 24, pp. 47-58 
504 |a Paez, P.M., García, C.I., Davio, C., Campagnoni, A.T., Soto, E.F., Pasquini, J.M., Apotransferrin promotes the differentiation of two oligodendroglial cell lines (2004) Glia, 46, pp. 207-217 
504 |a Saleh, M.C., Espinosa de los Monteros, A., de Arriba Zerpa, G.A., Fontaine, I., Piaud, O., Djordjijevic, D., Baroukh, N., Guillou, F., Myelination and motor coordination are increased in transferrin transgenic mice (2003) J. Neurosci. Res., 72, pp. 587-594 
504 |a Suzuki, K., Kikkawa, Y., Status spongiosus of CNS and hepatic changes induced by cuprizone (biscyclohexanone oxalyldihydrazone) (1969) Am. J. Pathol., 54, pp. 307-325 
520 3 |a Twenty-one-day-old Wistar rats were fed a diet containing 0.6% cuprizone for 2 weeks. Studies carried out after withdrawal of cuprizone showed histological evidences of marked demyelination in the corpus callosum. Biochemical studies of isolated myelin showed a marked decrease in myelin proteins, phospholipids, and galactocerebrosides as well as a marked decrease in myelin yield. Treatment of these animals with a single intracranial injection of 350 ng of apotransferrin at the time of withdrawal of cuprizone induced a marked increase in myelin deposition resulting in a significantly improved remyelination, evaluated by histological, immunocytochemical, and biochemical parameters, in comparison to what was observed in spontaneous recovery. Immunocytochemical studies of cryotome sections to analyze developmental parameters of the oligodendroglial cell population at the time of termination of cuprizone and at different times thereafter showed that in the untreated animals, there was a marked increase in the number of NG2-BrdU-positive precursor cells together with a marked decrease in MBP expression at the peak of cuprizone-induced demyelination. As expected, the amount of precursor cells decreased markedly during spontaneous remyelination and was accompanied by an increase in MBP reactivity. In the apotransferrin-treated animals, these phenomena occurred much faster, and remyelination was much more efficient than in the untreated controls. The results of this study suggest that apotransferrin is a very active promyelinating agent which could be important for the treatment of certain demyelinating conditions. © 2006 Elsevier Inc. All rights reserved.  |l eng 
536 |a Detalles de la financiación: Universidad de Buenos Aires 
536 |a Detalles de la financiación: This work has been supported by Grant 092 from the University of Buenos Aires. 
593 |a Instituto de Química y Físicoquímica Biológica (IQUIFIB), UBA-CONICET, Departamento de Química Biológica, Buenos Aires, C1113AAD, Argentina 
690 1 0 |a APOTRANSFERRIN 
690 1 0 |a CUPRIZONE 
690 1 0 |a DEMYELINATING DISEASES 
690 1 0 |a DEMYELINATION 
690 1 0 |a OLIGODENDROGLIAL CELL DIFFERENTIATION 
690 1 0 |a REMYELINATION 
690 1 0 |a APOTRANSFERRIN 
690 1 0 |a BROXURIDINE 
690 1 0 |a CUPRIZONE 
690 1 0 |a GALACTOSYLCERAMIDE 
690 1 0 |a MYELIN PROTEIN 
690 1 0 |a PHOSPHOLIPID 
690 1 0 |a ANIMAL EXPERIMENT 
690 1 0 |a ANIMAL MODEL 
690 1 0 |a ANIMAL TISSUE 
690 1 0 |a ARTICLE 
690 1 0 |a CHEMICAL ANALYSIS 
690 1 0 |a CONTROLLED STUDY 
690 1 0 |a CORPUS CALLOSUM 
690 1 0 |a DEMYELINATING DISEASE 
690 1 0 |a DEMYELINATION 
690 1 0 |a FEMALE 
690 1 0 |a HISTOLOGY 
690 1 0 |a IMMUNOCYTOCHEMISTRY 
690 1 0 |a MALE 
690 1 0 |a NONHUMAN 
690 1 0 |a PRIORITY JOURNAL 
690 1 0 |a PROTEIN EXPRESSION 
690 1 0 |a PROTEIN ISOLATION 
690 1 0 |a RAT 
690 1 0 |a REMYELINIZATION 
690 1 0 |a STATISTICAL SIGNIFICANCE 
690 1 0 |a STEM CELL 
690 1 0 |a ANALYSIS OF VARIANCE 
690 1 0 |a ANIMALS 
690 1 0 |a ANIMALS, NEWBORN 
690 1 0 |a ANTIGENS 
690 1 0 |a ANTIGENS, CD11B 
690 1 0 |a APOPROTEINS 
690 1 0 |a BRAIN 
690 1 0 |a BROMODEOXYURIDINE 
690 1 0 |a CELL COUNT 
690 1 0 |a CUPRIZONE 
690 1 0 |a CYTOSKELETAL PROTEINS 
690 1 0 |a DEMYELINATING DISEASES 
690 1 0 |a DRUG INTERACTIONS 
690 1 0 |a GALACTOLIPIDS 
690 1 0 |a GLIAL FIBRILLARY ACIDIC PROTEIN 
690 1 0 |a IMMUNOHISTOCHEMISTRY 
690 1 0 |a MYELIN BASIC PROTEINS 
690 1 0 |a MYELIN SHEATH 
690 1 0 |a PROTEOGLYCANS 
690 1 0 |a RATS 
690 1 0 |a RATS, WISTAR 
690 1 0 |a RECOVERY OF FUNCTION 
690 1 0 |a REGENERATION 
690 1 0 |a TIME FACTORS 
690 1 0 |a TRANSFERRIN 
650 1 7 |2 spines  |a INDOLES 
700 1 |a Paez, P.M. 
700 1 |a Escobar Cabrera, O.E. 
700 1 |a Wolfson, M. 
700 1 |a Franco, P.G. 
700 1 |a Pasquini, J.M. 
700 1 |a Soto, E.F. 
773 0 |d 2006  |g v. 198  |h pp. 519-529  |k n. 2  |p Exp. Neurol.  |x 00144886  |w (AR-BaUEN)CENRE-4716  |t Experimental Neurology 
856 4 1 |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-33645729410&doi=10.1016%2fj.expneurol.2005.12.027&partnerID=40&md5=8add0e451cec3b3bbdb54d594e6df386  |y Registro en Scopus 
856 4 0 |u https://doi.org/10.1016/j.expneurol.2005.12.027  |y DOI 
856 4 0 |u https://hdl.handle.net/20.500.12110/paper_00144886_v198_n2_p519_Adamo  |y Handle 
856 4 0 |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00144886_v198_n2_p519_Adamo  |y Registro en la Biblioteca Digital 
961 |a paper_00144886_v198_n2_p519_Adamo  |b paper  |c PE 
962 |a info:eu-repo/semantics/article  |a info:ar-repo/semantics/artículo  |b info:eu-repo/semantics/publishedVersion 
999 |c 82794